Skip to main content

Diversity in Early-Phase Cancer Trials Improved Since 2000

Medically reviewed by Drugs.com.

By Lori Solomon HealthDay Reporter

TUESDAY, Oct. 3, 2023 -- There have been some increases in diversity in early-phase cancer clinical trials since 2000, according to a study presented at the 16th AACR Conference on the Science of Cancer Health Disparities in Racial/Ethnic Minorities and the Medically Underserved, held from Sept. 29 to Oct. 2 in Orlando, Florida.

Maria Farooq, M.B.B.S., from the National Cancer Institute in Bethesda, Maryland, and colleagues used the National Cancer Institute Cancer Therapy Evaluation Program-sponsored early phase oncology clinical trials database to evaluate trends in disparities in patient enrollment during the last 22 years (2000 to 2022; 14,877 patients).

The researchers found that the proportion of patients aged 40 to 64 years at enrollment decreased from 59.8 percent in 2000-2003 to 47.5 percent in 2020-2022, with simultaneous increases in ages 65 to 74 years (24.2 to 32.9 percent) and 75 to 84 years (5.9 to 12.3 percent). There was a decline seen in non-Hispanic White participants, from 83.7 percent in 2000-2003 to 72.9 percent in 2020-2022. There were increases noted in Hispanic/Latino population enrollment (4.2 to 6.9 percent), as well as among the Asian/Pacific Islander population (2.5 to 5.4 percent) and for non-Hispanic Black patients (6.3 to 7.1 percent). Trial enrollment by geographic region was steady in the Northeast (23.9 to 20.8 percent), increased in the South and West overall (29.1 to 40.9 percent and 7.9 to 18.2 percent, respectively), and decreased in the Midwest (24.4 to 19.4 percent). There was a decrease observed in participation among patients traveling >200 miles to enroll in clinical trials (16.1 to 8.3 percent).

"Over the period evaluated, NCI-sponsored early-phase cancer clinical trials became more representative of the broader patient population," Farooq said in a statement. "These results are encouraging, but there is still substantial room for improvement in this area."

Press Release

 

Disclaimer: Statistical data in medical articles provide general trends and do not pertain to individuals. Individual factors can vary greatly. Always seek personalized medical advice for individual healthcare decisions.

© 2024 HealthDay. All rights reserved.

Posted October 2023

Read this next

First Responders With More Debris Exposure Have Higher Risk of Early Dementia

FRIDAY, June 14, 2024 -- More severe exposure to dust or debris among World Trade Center (WTC) responders is significantly associated with a higher risk of dementia at <65...

1990 to 2019 Saw Increase in Life Expectancy in Seniors With T1DM

FRIDAY, June 14, 2024 -- From 1990 to 2019, there was an increase in life expectancy in older people with type 1 diabetes mellitus (T1DM), according to a study published online...

Second Tumors Are Rare After Chimeric Antigen Receptor T-Cell Therapy

FRIDAY, June 14, 2024 -- Second tumors are rarely seen after chimeric antigen receptor (CAR) T-cell therapy, according to a study published in the June 13 issue of the New England...

More news resources

Subscribe to our newsletter

Whatever your topic of interest, subscribe to our newsletters to get the best of Drugs.com in your inbox.